Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Orally Administered Extract of Orthosiphon Stamineus (NuvastaticTM-C5OSEW5050ESA) in Patient With Breast Cancer Undergoing Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an oral extract (Nuvastatic) with chemotherapy in breast cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Nuvastatic

Snippet

Sponsor: Natureceuticals Sdn Bhd | Conditions: Breast Neoplasms, Fatigue | Phase 3 | Status: COMPLETED